Maryland biopharmaceutical company Cerecor has completed its acquisition of Wayne, Pennsylvania-based Aevi Genomic Medicine Inc. in a transaction involving two companies both focused on developing new therapies for rare pediatric diseases. The all-stock deal, first disclosed in December, carries a value up to $22.1 million. Aevi shareholders received $15.6 million in Cerecor (NASDAQ: CERC) stock, plus the potential for up to another $6.5 million in conditional payments. Those payments include $2…
from https://www.bizjournals.com/baltimore/news/2020/02/04/cerecor-completes-acquisition-of-pennsylvania.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/190648268502
No comments:
Post a Comment